Featured Research

from universities, journals, and other organizations

To improve lung cancer diagnosis, good medicine is a polymer pill

Date:
May 21, 2010
Source:
National Institute of Standards and Technology (NIST)
Summary:
Doctors may soon be able to diagnose lung cancer more effectively, thanks to scientists who have found ways both to increase the accuracy of computed tomography scans and to lessen the amount of time necessary to perceive telltale changes in lung tissue.

NIST's pill-sized ellipsoids, which mimic the density of tumors, show up clearly in this CT scan. The tumor mimics allow scientists to determine how well different measurement protocols reveal changes in tumor size.
Credit: NIST

Doctors may soon be able to diagnose lung cancer more effectively thanks to research performed at the National Institute of Standards and Technology (NIST), where scientists have found ways both to increase the accuracy of computed tomography (CT) scans and to lessen the amount of time necessary to perceive telltale changes in lung tissue.

For years, radiologists have determined the size of potentially cancerous lung nodules by measuring the largest distance across them as displayed on a computer screen in two dimensions. A method called RECIST is widely used for this purpose, but some members of the research community have suggested that three-dimensional analysis, or volumetrics, may provide a better way to determine the size of the nodules. Recently, a NIST team quantified this improvement: Volumetrics could allow physicians to notice volume changes that are up to 10 times smaller than RECIST can, potentially cutting diagnosis time from six months to four weeks -- a critical difference in terms of a patient's chance of survival.

CT scans combine a series of X-ray views taken from many different angles to produce cross-sectional images of the body, but there are several approaches to interpreting scan data, so NIST's Zachary Levine set out to determine which was best by creating a set of reference objects that could mimic potential lung tumors. His team measured 283 polymer-silicate ellipsoids of precise volume that resemble pills ranging from four to 11 mm in diameter.

"For diagnosis in the earliest stage of cancer, other studies have shown this is the size of nodule you want to be looking at," says Levine.

The team encased the mimics in foam rubber and put them into layered racks of a box akin to one that holds fishing tackle. Because foam appears transparent to the CT reconstruction, in a scan the denser mimics look very much like tumors. The team was then able to compare their ellipsoids' known volumes with what the volumetrics and RECIST methods indicated from the scan data.

"We found that volumetrics allows you to notice volume changes that are a factor of 10 smaller than RECIST can with a similar level of confidence," Levine says. "This implies that you could notice life-threatening changes from a follow-up scan performed only weeks after the first, instead of months."

Levine cautions that cancers often grow in strange shapes not resembling elliptical pills which can make a diagnosis more difficult, but that the study was a good start toward improving data interpretation.

"Our work only applies to the simplest of cases, but it's still a large class of lung cancers," he says.


Story Source:

The above story is based on materials provided by National Institute of Standards and Technology (NIST). Note: Materials may be edited for content and length.


Journal Reference:

  1. Zachary H. Levine, Bruce R. Borchardt, Nolan J. Brandenburg, Charles W. Clark, Bala Muralikrishnan, Craig M. Shakarji, Joseph J. Chen, Eliot L. Siegel. RECIST versus volume measurement in medical CT using ellipsoids of known size. Optics Express, 2010; 18 (8): 8151 DOI: 10.1364/OE.18.008151

Cite This Page:

National Institute of Standards and Technology (NIST). "To improve lung cancer diagnosis, good medicine is a polymer pill." ScienceDaily. ScienceDaily, 21 May 2010. <www.sciencedaily.com/releases/2010/04/100428121445.htm>.
National Institute of Standards and Technology (NIST). (2010, May 21). To improve lung cancer diagnosis, good medicine is a polymer pill. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/04/100428121445.htm
National Institute of Standards and Technology (NIST). "To improve lung cancer diagnosis, good medicine is a polymer pill." ScienceDaily. www.sciencedaily.com/releases/2010/04/100428121445.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins